Informed consent for clinical trials: In search of the "best" method

被引:92
作者
Edwards, SJL [1 ]
Lilford, RJ
Thornton, J
Hewison, J
机构
[1] Univ Birmingham, Dept Publ Hlth Med, Birmingham, W Midlands, England
[2] Univ Leeds, Inst Epidemiol, Leeds, W Yorkshire, England
[3] Univ Leeds, Dept Psychol, Leeds LS2 9JT, W Yorkshire, England
关键词
informed consent; clinical trials; radomised controlled trial; patient understanding; recruitment rate; anxiety;
D O I
10.1016/S0277-9536(98)00235-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To review the literature on comparisons between different methods of obtaining informed consent for clinical trials. Design: Eight hundred and twelve articles were traced, in the process of conducting a systematic review of the ethics of clinical trials, by searching a number of sources: bibliographic databases (Medline, Psychlit and BIDS science and social science indices), hand searches, personal contacts, an original collection and a systematic follow-up of reference lists. Fourteen research reports were found which provided comparative data on different methods of obtaining informed consent. Eleven of these used a randomised design. Studies were classified according to three outcome measures (anxiety, consent rate and understanding). Results: The results of the various studies suggest that giving people more information and more time to reflect tends to be associated with a lower consent rate. There seems to be an optimal level of information about side-effects such that patients are not overburdened by detail, while grasping the most important risks. More information in general is associated with greater awareness of the research nature of the trial, voluntariness of participation, right to withdraw and (available) alternative treatments. This result does not, however, er;rend to explanations of the concept of randomisation on which the literature is contradictory - sometimes more information is associated with increased understanding of the concept and sometimes it is not. Although divulging less information seems to be associated with less anxiety, there is evidence of an interaction with knowledge - high levels of knowledge are significantly associated with less anxiety, irrespective of consent method. The more that patients know before they are invited to participate in a trial, the better equipped they are to cope with the informed consent procedure. Conclusion: There is some evidence to suggest that there is an optimal amount of information which enhances patient understanding and which might, in turn, reduce anxiety. However, the studies were not altogether conclusive. More work needs to be carried out, especially on public understanding of science and on how different ways of explaining scientific concepts affect that understanding. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1825 / 1840
页数:16
相关论文
共 42 条
[31]   THE CONSENT FORM AS A POSSIBLE CAUSE OF SIDE-EFFECTS [J].
MYERS, MG ;
CAIRNS, JA ;
SINGER, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (03) :250-253
[32]  
Oddens B J, 1992, Ned Tijdschr Geneeskd, V136, P2272
[33]   INFORMED CONSENT FOR INVESTIGATIONAL CHEMOTHERAPY - PATIENTS AND PHYSICIANS PERCEPTIONS [J].
PENMAN, DT ;
HOLLAND, JC ;
BAHNA, GF ;
MORROW, G ;
SCHMALE, AH ;
DEROGATIS, LR ;
CARNRIKE, CL ;
CHERRY, R .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) :849-855
[34]   RECRUITING PATIENTS TO CLINICAL-TRIALS - LESSONS FROM STUDIES OF GROWTH-HORMONE TREATMENT IN RENAL-FAILURE [J].
POSTLETHWAITE, RJ ;
REYNOLDS, JM ;
WOOD, AJ ;
EVANS, JHC ;
LEWIS, MA ;
EMINSON, DM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (01) :30-35
[35]   PATIENT MOTIVATION AND INFORMED CONSENT IN A PHASE-I STUDY OF AN ANTICANCER AGENT [J].
RODENHUIS, S ;
VANDENHEUVEL, WJA ;
ANNYAS, AA ;
KOOPS, HS ;
SLEIJFER, DT ;
MULDER, NH .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (04) :457-462
[36]  
Silva Mary Cipriano, 1988, IRB, V10, P1, DOI 10.2307/3564101
[37]   A RANDOMIZED CONTROLLED TRIAL COMPARING QUANTITATIVE INFORMED CONSENT FORMATS [J].
SIMEL, DL ;
FEUSSNER, JR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (08) :771-777
[38]   RANDOMIZED COMPARISON OF PROCEDURES FOR OBTAINING INFORMED CONSENT IN CLINICAL-TRIALS OF TREATMENT FOR CANCER [J].
SIMES, RJ ;
TATTERSALL, MHN ;
COATES, AS ;
RAGHAVAN, D ;
SOLOMON, HJ ;
SMARTT, H .
BRITISH MEDICAL JOURNAL, 1986, 293 (6554) :1065-1068
[39]   FACTORS AFFECTING TREATMENT DECISIONS FOR A LIFE-THREATENING ILLNESS - THE CASE OF MEDICAL-TREATMENT OF BREAST-CANCER [J].
SIMINOFF, LA ;
FETTING, JH .
SOCIAL SCIENCE & MEDICINE, 1991, 32 (07) :813-818
[40]   EFFECTS OF 2 FORMATS OF INFORMED CONSENT ON KNOWLEDGE AMONGST PERSONS WITH ADVANCED HIV-DISEASE IN A CLINICAL-TRIAL OF DIDANOSINE [J].
TINDALL, B ;
FORDE, S ;
ROSS, MW ;
GOLDSTEIN, D ;
BARKER, S ;
COOPER, DA .
PATIENT EDUCATION AND COUNSELING, 1994, 24 (03) :261-266